We are live on
!
Find out more
Pacific Biosciences
PACB
PACB
208 hedge funds and large institutions have $238M invested in Pacific Biosciences in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 61 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
181% more call options, than puts
Call options by funds: $2.87M | Put options by funds: $1.02M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
0% more funds holding
Funds holding: 207 → 208 (+1)
3% less capital invested
Capital invested by funds: $246M → $238M (-$8M)
8% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 61
4.14% less ownership
Funds ownership: 66.14% → 62% (-4.1%)
Holders
208
Holders Change
+1
Holders Change %
+0.48%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
56
Reduced
61
Closed
25
Calls
$2.87M
Puts
$1.02M
Net Calls
+$1.84M
Net Calls Change
+$2.31M
Top Buyers
| 1 |
Millennium Management
New York
|
+$5.48M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.38M |
| 3 |
PD
Point72 (DIFC)
Dubai,
United Arab Emirates
|
+$2.45M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.04M |
| 5 |
Squarepoint
New York
|
+$863K |
